On October 31, 2024, Baroness Susan Greenfield delivered a thought-provoking speech in the House of Lords on the critical impact of science and technology on the UK economy. She emphasized the need for enhanced investment in biotech, especially for tackling Alzheimer’s, an area overlooked in current frameworks. She highlighted challenges like diminishing R&D tax credits, reduced funding opportunities for SMEs, and low venture capital access for female founders. Baroness Greenfield advocated a stronger national strategy prioritising science funding, innovation, and equality to keep UK research competitive globally. Watch her speak below:
LATEST NEWS
- Neuro-Bio’s first paper of 2026 has been published!
- Jo Hayman from Rathbones (UK-based investment and wealth management company) visits Neuro-Bio!
- CEO and Founder Baroness Greenfield and CSO Dr Sara Garcia Ratés meet with Dalloway Partners to discuss pioneering science and innovative ventures
- CEO & Founder Baroness Susan Greenfield visits San Raffaele Hospital in Milan!
- Neuro-Bio featured in Corriere Salute – a health & wellbeing section of Corriere della Sera, one of Italy’s most established and widely read national newspapers!